Fidelity Disruptive Medicine Fund (FRXNX)
Nasdaq - Nasdaq Delayed price. Currency in USD
Add to watchlist
At close: 09:01PM EDT
Overall portfolio composition (%)
Cash0.54%
Stocks99.45%
Bonds0.00%
Others0.00%
Preferred0.00%
Convertible0.00%
Sector weightings (%)
Sector(s)FRXNX
Basic materials0.00%
Consumer cyclical0.00%
Financial services0.00%
Property0.00%
Consumer defensive0.00%
Healthcare99.46%
Utilities0.00%
Communication services0.00%
Energy0.00%
Industrials0.00%
Technology0.00%
Equity holdings
AverageFRXNXCategory average
Price/Earnings0.0324.55
Price/book0.195.28
Price/sales0.322.06
Price/Cash flow0.0517.54
Median market cap22,410.3734,862.81
3-year earnings growth5.7632.48
Bond holdings
AverageFRXNXCategory average
MaturityN/AN/A
DurationN/AN/A
Credit qualityN/AN/A
Bond ratings
Sector(s)FRXNX
US government0.00%
AAAN/A
AAN/A
AN/A
BBBN/A
BBN/A
BN/A
Below BN/A
OthersN/A
Top 10 holdings (38.19% of total assets)
Get quotes for top holdings| Name | Symbol | % assets |
|---|---|---|
| Insulet Corp | PODD | 4.66% |
| Boston Scientific Corp | BSX | 4.36% |
| Penumbra Inc | PEN | 3.99% |
| UnitedHealth Group Inc | UNH | 3.90% |
| Humana Inc | HUM | 3.76% |
| Eli Lilly and Co | LLY | 3.61% |
| Bruker Corp | BRKR | 3.58% |
| Danaher Corp | DHR | 3.52% |
| Royalty Pharma PLC Class A | RPRX | 3.47% |
| Vertex Pharmaceuticals Inc | VRTX | 3.35% |
© 2024 Yahoo. All rights reserved.